Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.55 |
| ▸ | KMO | O15229 | 5/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9812604 | 0.84 | HSP90AA1 (0.49) | TSHRSRD5A2KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL27793384 | 0.83 | TSHR (0.57) | TSHRSRD5A2KMOMEN1KMT2A | |
| SCHEMBL31620838 | 0.82 | MAPT (0.49) | TSHRSRD5A2MEN1KMT2ANPC1 | |
| SCHEMBL11655118 | 0.82 | TSHR (0.61) | TSHRSRD5A2KMOMEN1KMT2A | |
| SCHEMBL28259354 | 0.80 | TDP1 (0.48) | TSHRSRD5A2MAOAMAOB | |
| SCHEMBL906513 | 0.78 | TSHR (0.68) | TSHRSRD5A2KMOMEN1KMT2A | |
| SCHEMBL11320111 | 0.78 | KMT2A (0.50) | TSHRMEN1KMT2AKDM4ENPC1 | |
| SCHEMBL29240129 | 0.78 | SRD5A2 (0.46) | TSHRSRD5A2KMT2AKDM4EMAPT | |
| SCHEMBL31059293 | 0.78 | KDR (0.49) | MAPT | |
| SCHEMBL371998 | 0.78 | TSHR (1.00) | TSHRSRD5A2KMOMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109843866-A | YAP1 inhibitors targeting YAP1 interaction with OCT4 | H·李·莫菲特癌症中心研究有限公司 | 2019-06-04 | — | — | CN | disclosed |
| WO-2012142067-A2 | FORMULATIONS, SALTS, AND SOLID FORMS OF SUBSTITUTED CYCLOHEXYLMETHANAMINES, PROCESSES FOR PREPARATION, AND USES THEREOF | SUNOVION PHARMACEUTICALS INC. (US) | 2012-10-18 | — | — | WO | disclosed |
| WO-2012142067-A2 | FORMULATIONS, SALTS, AND SOLID FORMS OF SUBSTITUTED CYCLOHEXYLMETHANAMINES, PROCESSES FOR PREPARATION, AND USES THEREOF | SUNOVION PHARMACEUTICALS INC. (US) | 2012-10-18 | — | — | WO | disclosed |
| EP-1009405-A4 | PYRROLIDINE AND PIPERIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | MERCK & CO INC (US) | 2001-05-09 | — | — | EP | disclosed |
| US-6166037-A | Pyrrolidine and piperidine modulators of chemokine receptor activity | MERCK & CO., INC. (US) | 2000-12-26 | — | — | US | disclosed |
| EP-1009405-A1 | PYRROLIDINE AND PIPERIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Merck & Co., Inc. (US) | 2000-06-21 | — | — | EP | disclosed |
| WO-1999009984-A1 | PYRROLIDINE AND PIPERIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | MERCK & CO., INC. (US) | 1999-03-04 | — | — | WO | disclosed |
| US-4302484-A | Polymers crosslinkable by electron beams | BAYER AKTIENGESELLSCHAFT (DE) | 1981-11-24 | — | — | US | disclosed |